BioSpace News Archive

Business

Translate Bio Announces First Quarter 2021 Financial Results and Provides Corporate Update

Advanced infectious disease vaccine programs with Sanofi Pasteur through initiation of COVID-19 clinical trial and publication of preclinical results; Influenza trial anticipated to begin mid-year

May 6, 2021
·
14 min read
Business

Mirati Therapeutics Reports First Quarter 2021 Financial Results and Recent Corporate Updates

Initiated potentially registration-enabling trials evaluating our investigational KRASG12C inhibitor, adagrasib, in lung and colorectal cancers, as monotherapy and with other agents

May 6, 2021
·
9 min read
Business

Athersys Reports First Quarter 2021 Results

Athersys, Inc. (NASDAQ: ATHX) announced today its financial results for the three months ended March 31, 2021 and provided a corporate update.

May 6, 2021
·
11 min read
Business

Guardant Health Reports First Quarter 2021 Financial Results

Guardant Health, Inc., a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, reported financial results for the quarter ended March 31, 2021.

May 6, 2021
·
14 min read
Business

Fulgent Genetics Reports Record First Quarter Financial Results

Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “company”), a technology company providing large-scale COVID-19 testing services and comprehensive testing solutions through its scalable technology platform, today announced financial results for its first quarter ended March 31, 2021.

May 6, 2021
·
14 min read
Business

BeiGene Reports First Quarter 2021 Financial Results

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a global biotechnology company focused on developing and commercializing innovative medicines worldwide, today reported recent business highlights, anticipated upcoming milestones, and financial results for the first quarter of 2021

May 6, 2021
·
20 min read
Business

Kadmon Provides Business Update and Reports First Quarter 2021 Financial Results

Kadmon Holdings, Inc. provided a business update and reported financial and operational results for the first quarter of 2021.

May 6, 2021
·
8 min read
Business

Exelixis Announces First Quarter 2021 Financial Results and Provides Corporate Update

Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the first quarter of 2021 and provided an update on progress toward achieving key corporate objectives, as well as commercial, clinical and pipeline development milestones.

May 6, 2021
·
23 min read
Drug Development

EVERSANA advances commercialization readiness as Humanigen announces publication of phase 3 randomized double-blind placebo-controlled study demonstrating the efficacy and safety of lenzilumab™ in newly hospitalized COVID-19 patients

EVERSANA, a pioneer of next generation services to the global life sciences industry, today congratulated its partner, Humanigen, on the publication of positive results from the lenzilumab LIVE-AIR Phase 3 study in newly hospitalized COVID-19 patients.

May 6, 2021
·
3 min read
Business

NovaBay Pharmaceuticals Reports First Quarter 2021 Financial Results

NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reports financial results for the three months ended March 31, 2021 and provides a business update.

May 6, 2021
·
9 min read